• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解克罗恩病成年患者和医生对全肠内营养的看法:弥合营养治疗差距

Understanding Patient and Physician Perspectives on Exclusive Enteral Nutrition in Adults with Crohn's Disease: Bridging the Gap in Nutritional Therapy.

作者信息

Magen-Rimon Ramit, Mamet David, Assaf Meis, Tal-Leshinsky Zohar, Libman Oxana, Waterman Matti, Bar-Yoseph Haggai

机构信息

Pediatric Gastroenterology Institute, Rambam Health Care Campus, Haifa 3109601, Israel.

The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

出版信息

Nutrients. 2025 Sep 12;17(18):2945. doi: 10.3390/nu17182945.

DOI:10.3390/nu17182945
PMID:41010471
Abstract

Exclusive enteral nutrition (EEN) effectively induces remission in pediatric Crohn's disease (CD), but reasons for its limited use in adults remain unclear. This study aimed to identify and compare patients' and physicians' perspectives on barriers to EEN use, in order to inform strategies to enhance its utilization. An online questionnaire was distributed to adult CD patients and gastroenterologists, collecting data on demographics, disease characteristics, previous EEN exposure, and attitudes toward EEN and potential barriers (Likert scale 1-5). Comparative analysis and logistic regression identified factors associated with reluctance toward EEN. A total of 315 CD patients (mean age 36.7) and 42 physicians completed the survey. Previous EEN use was reported by 40%, while 20.3% of the entire cohort were reluctant to use it. The only factor that predicted reluctance was current use of advanced therapy (OR 2.06 [95%CI 1.05-4.35]). Among physicians, 71% had prescribed EEN, and 81% were willing to do so. Key barriers were lack of food variety (65% Likert score > 3) and reduced social interaction (59%) among patients and social interaction (67.3%) and taste concerns (54.7%) among physicians. Patients rated hunger sensation and lack of food variety concerns as more significant barriers than physicians. Patients identified direct communication with staff (68.6% Likert score > 3) and full cost coverage (65%) as facilitators for adherence. Notably, 87% wanted more information from their doctors. Most adult CD patients and physicians are open to discuss EEN. Removing barriers related to palatability and diversity of enteral nutrition, as well as shortening of EEN duration, may enhance acceptance of and adherence to EEN.

摘要

全肠内营养(EEN)可有效诱导小儿克罗恩病(CD)缓解,但在成人中使用受限的原因尚不清楚。本研究旨在确定并比较患者和医生对EEN使用障碍的看法,以便为提高其利用率提供策略依据。向成年CD患者和胃肠病学家发放了一份在线问卷,收集有关人口统计学、疾病特征、既往EEN接触情况以及对EEN的态度和潜在障碍的数据(李克特量表1 - 5)。比较分析和逻辑回归确定了与不愿使用EEN相关的因素。共有315名CD患者(平均年龄36.7岁)和42名医生完成了调查。40%的患者报告曾使用过EEN,而整个队列中有20.3%的患者不愿使用。唯一预测不愿使用的因素是当前正在使用高级疗法(比值比2.06 [95%置信区间1.05 - 4.35])。在医生中,71%曾开具过EEN处方,81%愿意这样做。主要障碍包括患者缺乏食物多样性(65%李克特评分>3)和社交互动减少(59%),以及医生方面的社交互动(67.3%)和口味担忧(54.7%)。患者将饥饿感和缺乏食物多样性担忧视为比医生更重要的障碍。患者认为与工作人员直接沟通(68.6%李克特评分>3)和全额费用覆盖(65%)是坚持使用EEN的促进因素。值得注意的是,87%的患者希望从医生那里获得更多信息。大多数成年CD患者和医生愿意讨论EEN。消除与肠内营养的适口性和多样性相关的障碍,以及缩短EEN疗程,可能会提高对EEN的接受度和依从性。

相似文献

1
Understanding Patient and Physician Perspectives on Exclusive Enteral Nutrition in Adults with Crohn's Disease: Bridging the Gap in Nutritional Therapy.了解克罗恩病成年患者和医生对全肠内营养的看法:弥合营养治疗差距
Nutrients. 2025 Sep 12;17(18):2945. doi: 10.3390/nu17182945.
2
Enteral nutritional therapy for inducing remission of Crohn's disease.诱导克罗恩病缓解的肠内营养疗法。
Cochrane Database Syst Rev. 2001(3):CD000542. doi: 10.1002/14651858.CD000542.
3
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD000542. doi: 10.1002/14651858.CD000542.pub2.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.中重度溃疡性结肠炎和克罗恩病对性活动的影响:来自炎症性肠病经历的沟通需求与特征(CONFIDE)调查的美国和欧洲患者观点
Curr Med Res Opin. 2025 Jul 17:1-14. doi: 10.1080/03007995.2025.2530736.
6
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
7
Mid Forehead Brow Lift额中眉提升术
8
The effect of solid food diet therapies on the induction and maintenance of remission in Crohn's disease: a systematic review.固体食物饮食疗法对克罗恩病诱导和维持缓解的影响:系统评价。
BMC Gastroenterol. 2024 Aug 6;24(1):250. doi: 10.1186/s12876-024-03315-7.
9
Vesicoureteral Reflux膀胱输尿管反流
10
Exclusive enteral nutrition in Crohn's disease pediatric patients: from clinical remission to transmural healing.克罗恩病儿科患者的全肠内营养:从临床缓解到透壁愈合
Med Pharm Rep. 2025 Jul;98(3):371-380. doi: 10.15386/mpr-2900. Epub 2025 Jul 30.

本文引用的文献

1
ECCO Consensus on Dietary Management of Inflammatory Bowel Disease.欧洲克罗恩病和结肠炎组织(ECCO)关于炎症性肠病饮食管理的共识
J Crohns Colitis. 2025 Jul 12. doi: 10.1093/ecco-jcc/jjaf122.
2
An Overview of Nutritional Interventions in Inflammatory Bowel Diseases.炎症性肠病的营养干预概述。
Nutrients. 2024 Sep 10;16(18):3055. doi: 10.3390/nu16183055.
3
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.欧洲克罗恩病治疗指南:药物治疗
J Crohns Colitis. 2024 Oct 15;18(10):1531-1555. doi: 10.1093/ecco-jcc/jjae091.
4
Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study.生物制剂与专用肠内营养联合治疗以回肠为主的克罗恩病患者的真实世界证据:一项多中心研究。
Clin Nutr. 2024 Jun;43(6):1291-1298. doi: 10.1016/j.clnu.2024.04.013. Epub 2024 Apr 15.
5
Nutritional aspects of inflammatory bowel disease.炎症性肠病的营养方面
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(7):731-740. doi: 10.1080/17474124.2023.2231340. Epub 2023 Jul 10.
6
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.炎症性肠病患者治疗维持方案的比较可接受性:全国性ACCEPT2研究结果
Inflamm Bowel Dis. 2023 Apr 3;29(4):579-588. doi: 10.1093/ibd/izac119.
7
Exclusive Enteral Nutrition in Adult Crohn's Disease: an Overview of Clinical Practice and Perceived Barriers.成人克罗恩病的肠内营养:临床实践及认知障碍概述
Clin Exp Gastroenterol. 2021 Dec 29;14:493-501. doi: 10.2147/CEG.S267172. eCollection 2021.
8
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.成人轻至中度克罗恩病缓解诱导和维持的克罗恩病排除饮食(CDED-AD):一项开放标签、先导性随机试验。
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):49-59. doi: 10.1016/S2468-1253(21)00299-5. Epub 2021 Nov 2.
9
Review of exclusive enteral therapy in adult Crohn's disease.成人克罗恩病的肠内营养治疗综述。
BMJ Open Gastroenterol. 2021 Sep;8(1). doi: 10.1136/bmjgast-2021-000745.
10
Exclusive enteral nutrition in the management of Crohn's disease: a qualitative exploration of experiences, challenges and enablers in adult patients.克罗恩病管理中的肠内营养支持:成人患者体验、挑战和促成因素的定性探索。
J Hum Nutr Diet. 2021 Apr;34(2):440-449. doi: 10.1111/jhn.12829. Epub 2020 Oct 22.